IQVIA Selected Veeva Clinical Applications
IQVIA has expanded its partnership with Veeva to standardize clinical operations technology across its global research studies.
Updated on Oct. 13, 2026 in Biotech
Live Poll
Do you trust that deeper integration between major healthcare technology providers improves medical trial results?
IQVIA has selected a suite of Veeva applications to serve as the enterprise standard for its clinical development studies. This expansion of their existing corporate partnership aims to increase the speed and efficiency of clinical trials.
Why it matters
The integration aims to improve clinical decision-making and site centricity across research projects. Sponsors working with IQVIA can now access a comprehensive technology stack to streamline the development process.
IQVIA has integrated Veeva CTMS, eTMF, Study Startup, and Site Connect applications into its clinical operations. These tools serve as the standardized technology stack for studies managed by the organization across 100 countries.
The players
IQVIA
IQVIA is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry.
Veeva
Veeva is a cloud-computing company that focuses on pharmaceutical and life sciences industry applications.
The details
Clinical study teams at IQVIA will utilize the new applications to enhance trial workflows and data management. The deal builds upon a previous partnership focused on electronic data capture (EDC) technology.
Timeline
October 13, 2026: The partnership expansion was officially announced.
October 20-21, 2026: The Veeva R&D and Quality Summit is scheduled to take place in Boston.
The Tech Race
This move reflects a broader trend of digitizing and consolidating trial management infrastructure within the life sciences sector. It positions IQVIA to compete more effectively by utilizing the Veeva clinical data management cloud suite to replace fragmented legacy systems.
Sponsors and clinical trial partners may experience improved trial efficiency and faster site communication through the integrated technology stack. These improvements are designed to facilitate faster data exchange and decision-making for ongoing global studies.
The takeaway
The partnership highlights the industry-wide push for standardized digital platforms to handle increasingly complex global clinical trials. Companies and researchers should expect a greater emphasis on unified cloud-based software to manage site operations in the future.
What happens next
The Veeva R&D and Quality Summit is scheduled to be held in Boston on October 20-21, 2026.
Further reading
Learn more about the latest industry developments in our Biotech section.
Live Poll
Do you trust that deeper integration between major healthcare technology providers improves medical trial results?
